Curewell Capital acquired the target/assets from Wilmington PharmaTech in a Private Equity transaction on not available.
Deal value was 3600000000 Sector: Healthcare; Location: USA.
On the acquirer side, not available advised, led by Adam Wexner, Marion Racine, Jane Guo, Yangxier Sui, Rachel Cantor, Rory Minnis, Michelle Kilkenney, Alex Bender, Dennis Williams, Will Richmond, Brian King.
Generated by AI, original source from - Data is in progress
Wilmington PharmaTech advisor
Firm name is in progress
Found it useful? Spread the word.
Kirkland & Ellis advises Curewell Capital on investment in Wilmington PharmaTech | The Sponsor - The Sponsor
